Is IBS Calling the Shots in Your Life?
We're looking for adults whose IBS symptoms show up most weeks, to help us learn more about a new approach that may ease pain and bring more predictability to your gut.
What is this study about?
This study is looking at a new investigational medication for adults living with IBS-D (the diarrhea-predominant type) or IBS-M (the mixed type, where symptoms go back and forth between diarrhea and constipation).
The idea behind this medication is that it may help calm down overactive nerve signals in the gut, the kind of signals that can lead to abdominal pain, urgency, and unpredictable bowel habits. Researchers want to find out whether it can ease pain, improve bowel symptoms, and whether it's safe and well tolerated.
As with most studies of this kind, not everyone who takes part will receive the new medication. Some participants will be given an inactive pill (often called a placebo) instead, and neither you nor the study staff will know which one you're taking. This is simply one of the ways researchers are able to tell whether the medication itself is making a difference.
The medication being studied is taken as a pill, twice a day (morning and evening), at home. The study is divided into two parts. During the first part, you'll be on a steady routine. Depending on how things go, there's a chance your assignment could be adjusted partway through the study for the second part.
Who Qualifies to Participate?
This study is specifically looking for people whose IBS symptoms are more than just occasional or mild, meaning they show up often enough, and are noticeable enough, that they actually affect day-to-day life.
For the purposes of this study, here's a general profile of what an ideal participant would look like:
Study participation
This study takes place over a total of about one year (around 54 weeks), broken down into a few different periods.
Here's the general flow:
Altogether, that adds up to about 9 in-person visits spread across the full 8 months. All of these visits are outpatient, with no overnight stay required at any point during this study.
See if you qualify
Reach out to one of our friendly, knowledgeable recruiters. We’d love to hear from you.
Our phone number is 256-403-7711
Garrett
Sam
Stephanie
Ashley